His primary areas of investigation include Genetics, Diabetes mellitus, Internal medicine, Gene and Mutation. Anders Molven usually deals with Genetics and limits it to topics linked to Case-control study and Pancreatitis, Allele frequency, Lipase and Pseudogene. His studies deal with areas such as Pancreatic disease and Pancreas as well as Diabetes mellitus.
The various areas that Anders Molven examines in his Internal medicine study include Endocrinology and Phosphatidylinositol. His Gene research is multidisciplinary, relying on both Framingham Risk Score and Genetic testing. His Mutation research incorporates themes from GTPase and Noonan syndrome.
The scientist’s investigation covers issues in Internal medicine, Genetics, Endocrinology, Gene and Diabetes mellitus. His research on Internal medicine focuses in particular on Pancreas. His study in Pancreas is interdisciplinary in nature, drawing from both Magnetic resonance imaging, Pancreatic cancer and Pathology.
In his study, which falls under the umbrella issue of Endocrinology, Family history is strongly linked to Proband. His research investigates the connection between Gene and topics such as Molecular biology that intersect with issues in Variable number tandem repeat, Lipase, Endoplasmic reticulum, Unfolded protein response and Mutant protein. In the field of Diabetes mellitus, his study on Type 1 diabetes, HNF1A and Type 2 diabetes overlaps with subjects such as Norwegian.
Anders Molven mainly investigates Internal medicine, Lipase, Molecular biology, Cancer research and Allele. His research integrates issues of Endocrinology and Oncology in his study of Internal medicine. His Endocrinology study integrates concerns from other disciplines, such as Missense mutation and PIK3R1.
Anders Molven has researched Molecular biology in several fields, including Secretion, Variable number tandem repeat, Mutant protein, Endoplasmic reticulum and Gene. His Allele study incorporates themes from Gastroenterology, Pancreatitis, Gene duplication and Pancreatic cancer. His work deals with themes such as Genetics, Wild type and Allele frequency, which intersect with Pancreatic disease.
Anders Molven mostly deals with Internal medicine, Genetics, Allele frequency, Pancreatic cancer and Pancreatic disease. His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Oncology and Cutaneous melanoma. His Endocrinology research incorporates elements of Autophagy, Missense mutation and PIK3R1.
The study incorporates disciplines such as Odds ratio, MODY 3 and Type 2 diabetes, Diabetes risk in addition to Allele frequency. His work carried out in the field of Pancreatic disease brings together such families of science as Copy-number variation, Variable number tandem repeat, Molecular biology, Genotyping and Gene duplication. He combines subjects such as Mutant protein and Gene, Allele, Locus, Candidate gene with his study of Molecular biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells.
Jian Wang;Per Ø. Sakariassen;Oleg Tsinkalovsky;Heike Immervoll;Heike Immervoll.
International Journal of Cancer (2008)
Neonatal diabetes mellitus due to complete glucokinase deficiency.
Pål R. Njølstad;Oddmund Søvik;Antonio Cuesta-Muñoz;Lise Bjørkhaug.
The New England Journal of Medicine (2001)
Loss-of-function mutations in SLC30A8 protect against type 2 diabetes
Jason Flannick;Jason Flannick;Gudmar Thorleifsson;Nicola L. Beer;Nicola L. Beer;Suzanne B R Jacobs.
Nature Genetics (2014)
Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy.
Jørn V. Sagen;Helge Ræder;Eba Hathout;Naim Shehadeh.
Diabetes (2004)
Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction.
Helge Raeder;Stefan Johansson;Pål I Holm;Pål I Holm;Ingfrid S Haldorsen.
Nature Genetics (2006)
Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter.
Anja Torsvik;Gro V. Røsland;Agnete Svendsen;Anders Molven.
Cancer Research (2010)
Genome-wide association study identifies three new melanoma susceptibility loci
Jennifer H. Barrett;Mark M. Iles;Mark Harland;John C. Taylor.
Nature Genetics (2011)
Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
Heike Immervoll;Heike Immervoll;Dag Hoem;Per Øystein Sakariassen;Ole Johnny Steffensen.
BMC Cancer (2008)
Ultrarapid metabolizers of debrisoquine: Characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene
Roger Løvlie;Ann K. Daly;Anders Molven;Jeffrey R. Idle;Jeffrey R. Idle.
FEBS Letters (1996)
Familial Hyperinsulinemic Hypoglycemia Caused by a Defect in the SCHAD Enzyme of Mitochondrial Fatty Acid Oxidation
Anders Molven;Guri E. Matre;Marinus Duran;Ronald J. Wanders.
Diabetes (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Bergen
Lund University
Leiden University Medical Center
Haukeland University Hospital
QIMR Berghofer Medical Research Institute
University of Barcelona
Harvard Medical School
Université Paris Cité
Hospital of the University of Pennsylvania
Grenoble Alpes University
Rutgers, The State University of New Jersey
University of Göttingen
University of Hong Kong
University of South Carolina
University of Illinois at Chicago
Aarhus University
Philipp University of Marburg
Aalto University
Örebro University
Stony Brook University
University of Michigan–Ann Arbor
Cincinnati Children's Hospital Medical Center
University of Bonn
Australian Catholic University
Grenoble Alpes University
Max Planck Society